GGrantIndex
Sort

261,768 grants matching gene therapy

Unlocking evolutionarily latent immune functions for treating disease

$1,165,316
Brenda L. Bass · University Of Utah · R01 · FY2024 · CA

DF/HCC Renal Cancer SPORE

$1,165,299
Michael B Atkins · Beth Israel Deaconess Medical Center · P50 · FY2008 · CA

Elucidating microvascular contributions to cognitive impairment at single-cell resolution

$1,165,270
Andrew Chris Yang · J. David Gladstone Institutes · R01 · FY2025 · NS

Malaria Parasite Ligands And Host Cell Receptors

$1,165,226
Louis Miller · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

STRUCTURE-BASED DESIGN PARADIGM:HIV Tat.PCAF INHIBITORS

$1,165,134
Mount Sinai School Of Medicine Of Nyu · P01 · FY2002 · GM

Program Project Grant: Bone Cell Structue and Gene Expression

$1,165,106
Gary S. Stein · Univ Of Massachusetts Med Sch Worcester · P01 · FY2011 · AR

FHS-SCAN Genome Wide Association Scan for Atherosclerosis Pathway Genes

$1,164,997
Michael A Province · Washington University · R01 · FY2007 · HL

Molecular Genetics Of Scrapie Pathogenesis

$1,164,826
Suzette Alise Priola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Tissue Processing-Sequencing Facility

$1,164,770
Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA

Transgenic animal production for neuroscience research

$1,164,601
James Pickel · National Institute Of Mental Health · Z01 · FY2008 · MH

Study of hereditary prostate cancer and human artificial chromosomes

$1,164,537
Vladimir Larionov · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

PROSTATE CANCER: TRANSITION TO ANDROGEN-INDEPENDENCE

$1,164,524
University Of North Carolina Chapel Hill · P01 · FY2001 · CA

Connecting Rare Mutations to Common Pathways

$1,164,521
Jeffrey D Milbrandt · Washington University · P50 · FY2025 · HD

NIDCD Core for Clinical Research and Care

$1,164,419
Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZID · FY2014 · DC

Dynamic State Space Modeling of Cancer Cell Response to Therapy

$1,164,374
Garry P Nolan · University Of Southern California · U54 · FY2012 · CA

Cincinnati Multidisciplinary Clinical Research Center

$1,164,366
Daniel Joe Lovell · Cincinnati Childrens Hosp Med Ctr · P60 · FY2011 · AR

Cincinnati Multidisciplinary Clinical Research Center

$1,164,269
Daniel Joe Lovell · Cincinnati Childrens Hosp Med Ctr · P60 · FY2009 · AR

Biomarkers of Catecholaminergic Neurodegeneration

$1,164,021
David Goldstein · National Institute Of Neurological Disorders And Stroke · ZIA · FY2022 · NS

Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer

$1,164,000
Reuben J Shaw · Salk Institute For Biological Studies · R35 · FY2018 · CA

Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer

$1,164,000
Reuben J Shaw · Salk Institute For Biological Studies · R35 · FY2020 · CA

Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer

$1,164,000
Reuben J Shaw · Salk Institute For Biological Studies · R35 · FY2021 · CA

CB1 Neutral Antagonists for Alcohol Use Disorder

$1,163,887
Alexandros Makriyannis · Northeastern University · U01 · FY2023 · AA

A Lung-chip microphysiological system to model SARS-CoV-2 infection and test novel therapeutics

$1,163,750
Clive Niels Svendsen · Cedars-Sinai Medical Center · UG3 · FY2020 · NS

NF Center: from animal models to therapeutics

$1,163,738
Luis F Parada · Ut Southwestern Medical Center · P50 · FY2010 · NS

Gene and Pharmacological Therapies for Cystic Fibrosis

$1,163,621
William B. Guggino · Johns Hopkins University · P01 · FY2009 · HL